About Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
ABMD - ABIOMED| Previous Close | $310.82 | Open | $306.96 |
| Volume | 137.9K | Market Cap | 14.188B |
| Yield | Last Dividend |
| ABIOMED (ABMD) Earnings and Revenues Bea... | 08/06/20 |
| ABIOMED's (ABMD) flagship Impella saw decline in revenues internationally and within the United States, in Q1. | |
| Abiomed???s Impella Scores Emergency FDA... | 08/04/20 |
| Abiomed (ABMD) has announced that the US Food and Drug Administration (FDA) has issued an emergency use authorization (EUA) for left-sided Impella hea... | |
| Abiomed's stock rises on second COVID-19... | 08/04/20 |
| Shares of Abiomed Inc. undefined rallied 2.0% in premarket trading on Tuesday after the company said its Impella heart pump had received an emergency ... | |
| ABIOMED Gets FDA Nod for First-in-Human ... | 06/08/20 |
| This regulatory approval is expected to boost ABIOMED's (ABMD) Impella product line. | |
| ABIOMED's (ABMD) Impella RP Receives FDA... | 06/03/20 |
| This regulatory approval is expected to boost ABIOMED's (ABMD) Impella product portfolio. | |
| Global Ventricular Assist Devices Market... | 06/02/20 |
| Technavio has been monitoring the global ventricular assist devices market and it is poised to grow by USD 943.27 million during 2020-2024, progressin... | |
| Abiomed???s Heart Pump Gets FDA Emergenc... | 06/01/20 |
| Abiomed (ABMD) said that the U.S. The post Abiomed???s Heart Pump Gets FDA Emergency Use Status For Covid-19 Patients appeared first on Smarter Analys... | |
| Why Is Abiomed (ABMD) Up 17.1% Since Las... | 05/30/20 |
| Abiomed (ABMD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. | |
| ABIOMED (ABMD) Q4 Earnings Beat Estimate... | 04/30/20 |
| ABIOMED's (ABMD) flagship Impella saw decline in revenues within United States in Q4. | |
| Infographic: Highlights of Abiomed (ABMD... | 04/30/20 |
| Medical device maker Abiomed, Inc. (NASDAQ: ABMD) reported a decline in fourth quarter earnings even as revenues remained flat. The results fell short... | |
| Abiomed Expands Product Portfolio with A... | 04/29/20 |
| Abiomed (NASDAQ: ABMD ), maker of the Impella heart pump, has acquired Breethe, developer of a novel extracorporeal membrane oxygenation (ECMO) system... | |
| ABIOMED (ABMD) to Report Q4 Earnings: Wh... | 04/24/20 |
| ABIOMED's (ABMD) fiscal fourth-quarter performance is likely to reflect growth in Impella product line. | |
| Earnings Preview: Abiomed (ABMD) Q4 Earn... | 04/23/20 |
| Abiomed (ABMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with t... | |
| Global Ventricular Assist Devices Market... | 03/27/20 |
| LONDON--(BUSINESS WIRE)-- #GlobalVentricularAssistDevicesMarket--The global ventricular assist devices (VAD) market has the potential to grow by USD 9... | |
| Abiomed announces measures amid COVID-19... | 03/25/20 |
| Abiomed (NASDAQ:ABMD) takes following steps during the COVID-19 outbreak. The company is adopting a work-from-home policy for all employees worldwide ... | |
| Abiomed???s Response to the COVID-19 Pan... | 03/25/20 |
| DANVERS, Mass.--(BUSINESS WIRE)--Abiomed (NASDAQ: ABMD), maker of the Impella heart pump, is taking a number of steps to aid the global medical commun... | |
| The Daily Biotech Pulse: Roche Obtains F... | 03/13/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 12.) ... | |
| The Daily Biotech Pulse: Mesoblast To Te... | 03/10/20 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) A... | |
| Abiomed (ABMD) Down 19.9% Since Last Ear... | 03/07/20 |
| Abiomed (ABMD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues. | |
| The Daily Biotech Pulse: Gilead Kicks Of... | 02/27/20 |
| The following is a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks that hit 52-week highs o... | |
| Abiomed (ABMD): A look at what lies ahea... | 02/12/20 |
| Shares of Abiomed Inc. (NASDAQ: ABMD) were down 4% in afternoon trade on Wednesday. The stock has dropped 22% over the past three months and??? | |
| ABIOMED (ABMD) Earnings Beat Estimates i... | 02/06/20 |
| Flagship Impella drives ABIOMED's (ABMD) fiscal third-quarter results; FY20 revenue guidance slashed. | |
| ABIOMED (ABMD) Announces Preliminary Q3 ... | 01/14/20 |
| ABIOMED's (ABMD) Q3 international revenues grew year over year; fiscal 2020 view slashed. | |
| 10 Worst Performing S&P 500 Stocks Of 20... | 12/24/19 |
| The S&P 500 had another big year this year, gaining more than 28% year to date. Most U.S. investors had a lot of winners in their portfolios this year... | |
| Global Ventricular Assist Devices Market... | 12/03/19 |
| LONDON--(BUSINESS WIRE)-- #Healthcare--Global ventricular assist devices market is poised to grow by USD 943.27 million during 2020-2024 at a CAGR of ... | |
| Abiomed Medical Office Completes Review ... | 11/19/19 |
| Abiomed (NASDAQ: ABMD ) is committed to improving patient outcomes by performing FDA studies and post-market surveillance, collecting real-world evide... | |
| Abiomed (ABMD) Earnings Expected to Grow... | 10/24/19 |
| Abiomed (ABMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with t... | |
| Hedge Funds Aren???t Crazy About ABIOMED... | 10/20/19 |
| Does ABIOMED, Inc. (NASDAQ:ABMD) represent a good buying opportunity at the moment? Let???s quickly check the hedge fund interest towards the company.... | |
| The Daily Biotech Pulse: UCB To Buy Ra P... | 10/10/19 |
| Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Oct. 9) A... | |
| The Daily Biotech Pulse: FDA Approves Cl... | 10/09/19 |
| The following is a roundup of top developments in the biotech space over the last 24 hours. None of the NYSE or Nasdaq-listed biotech stocks hit 52-we... | |
| Buy rating | 08/07/20 |
| SVB Leerink maintains Market Perform rating and raises Price Target from $280.00 to $335.00 | |
| Sell rating | 08/07/20 |
| Morgan Stanley maintains Underweight rating and raises Price Target from $152.00 to $217.00 | |
| Buy rating | 05/28/20 |
| and raises Price Target from $195.00 to $225.00 | |
| Date | 2020-08-06 (BMO) | Est. (EPS/Rev.) | $0.29/ 151.11M |
| Actual (EPS/Rev.) | $0.58/ $164.85 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| TopFlight Trades - Premium (Options) | Eric Cunningham | 51.00 % | Follow |
| Silent swinger | hasmat | 42.00 % | Follow |
| Optioneering-W | Sam Allen | 41.00 % | Follow |
| TopFlight Trades - Premium (Stocks) | Eric Cunningham | 38.00 % | Follow |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
